Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
Table of Contents<br />
<strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong> ......................................................................................................... 382<br />
<strong>LDMS</strong> Primary <strong>Codes</strong> .............................................................................................................. 383<br />
<strong>LDMS</strong> Additive <strong>Codes</strong> .............................................................................................................. 384<br />
<strong>LDMS</strong> Derivative <strong>Codes</strong> .......................................................................................................... 385<br />
<strong>LDMS</strong> Sub Additive/Derivative <strong>Codes</strong> ..................................................................................... 387<br />
<strong>LDMS</strong> Miscellaneous <strong>Codes</strong> ................................................................................................... 389<br />
Measurement....................................................................................................................... 389<br />
VID Units ............................................................................................................................. 389<br />
Time Units ........................................................................................................................... 389<br />
Conditions ............................................................................................................................ 389<br />
<strong>LDMS</strong> Assay Censor <strong>Codes</strong> .................................................................................................... 390<br />
Specimen Management ...................................................................................................... 390<br />
Immunology ......................................................................................................................... 390<br />
Pharmacology...................................................................................................................... 390<br />
Virology ................................................................................................................................ 391<br />
© 2011 Frontier Science Foundation 382 September 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>LDMS</strong> Primary <strong>Codes</strong><br />
Refer to the <strong>LDMS</strong> Reports module for a complete listing of <strong>LDMS</strong> <strong>Codes</strong>.<br />
APP Air Pollution Particles MSB Main Stem Bronchus Wash<br />
AMN Amniotic Fluid MEC Meconium<br />
ANL Anal NAS Nasal<br />
ART Arterial Blood Draw NPH Nasopharyngeal<br />
BLD Blood (Whole) NPW Nasopharyngeal Wash<br />
FST Blood from Fingerstick ORL Oral<br />
HST Blood from Heelstick ORH Oropharyngeal<br />
BMA Bone Marrow Aspirate OPW Oropharyngeal Wash<br />
BMC Bone Marrow Core Biopsy OTH Other<br />
BRN Brain Tissue PEN Penis<br />
BMK Breast Milk FSI Penis Foreskin, Inner Tissue<br />
BML Breast Milk - Left FSO Penis Foreskin, Outer Tissue<br />
BMR Breast Milk - Right FSK Penis Foreskin, Whole Tissue<br />
BRS Breast Tissue PAN Perianal<br />
BAL Bronchoalveolar Lavage PHX Pharynx<br />
BRB Bronchoscopy Brush PLC Placental Tissue<br />
BUC Buccal Cells PLQ Plaque<br />
CSF Cerebro-Spinal Fluid PFL Pleural Fluid<br />
CVB Cervical Biopsy/Aspirate PRT Prostate Tissue Biopsy<br />
CXC Cervical Culturette REC Rectal<br />
CSC Cervical Secretion ARB Rectal Biopsy by Anoscopy<br />
CXS Cervical Swab FSR Rectal Biopsy by Flexible Sigmoidoscopy<br />
CVL Cervical Vaginal Lavage RSC Rectosigmoid Colon<br />
CER Cervix SAL Saliva<br />
CRD Cord Blood SCR Scrotum<br />
EYE Corneal Tissue SEM Semen<br />
DIA Dialysate<br />
FSC Sigmoid Colon Biopsy by Flexible<br />
Sigmoidoscopy<br />
DPL Dried Plasma SKN Skin<br />
DWB Dried Whole Blood SLU Skin Lesion<br />
END Endometrium SPL Spleen<br />
EBC Exhaled Breath Condensate SPT Sputum<br />
EPS Expressed Prostatic Secretions SPI Sputum, Induced<br />
GAS Gastric Secretions SIN Sputum, Induced Non-Select<br />
GLU Genital Lesion/Ulcer SIS Sputum, Induced Select<br />
GCF Gingival Crevicular Fluid SPS Sputum, Spontaneous<br />
GLN Glans SSN Sputum, Spontaneous Non-Select<br />
HAR Hair SSS Sputum, Spontaneous Select<br />
BHR Hair, Body STL Stool<br />
FHR Hair, Facial TER Tears<br />
PHR Hair, Pubic THR Throat Swab<br />
SHR Hair, Scalp THW Throat Wash<br />
INW Induction Waste THY Thymus<br />
INT Intestinal Biopsy/Aspirate TON Tonsillar Biopsy/Aspirate<br />
IVR Intra-vaginal Ring TCA Tracheal Aspirate<br />
KID Kidney Biopsy UNK Unknown Primary<br />
LBT Lateral Border of the Tongue UTH Urethra<br />
LPK Leukopak URN Urine<br />
LIV Liver Tissue VGL Vaginal<br />
LUE Lung, Excised VSC Vaginal Secretions<br />
LUF Lung, Filter Paper VAG Vaginal Swab<br />
LYM Lymph Node Biopsy/Aspirate VUL Vulva<br />
WAR Warts<br />
Frontier Science Foundation 383 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>LDMS</strong> Additive <strong>Codes</strong><br />
Refer to the <strong>LDMS</strong> Reports module for a complete listing of <strong>LDMS</strong> <strong>Codes</strong>.<br />
ACD Acid Citrate Dextrose PFM Paraformaldahyde<br />
AHP Ammonium Heparin PAX PAXgene Blood RNA tube<br />
BTM Biopsy Transport Media PBS Phosphate Buffered Saline<br />
BOR Boric Acid PPT Plasma Preparation Tube<br />
CPH Cell Preparation Tube Heparin PLP PLP Fixative<br />
CPS Cell Preparation Tube SCI PAC Port-a-cul Transport Tube<br />
CPD Citrate Phosphate Dextrose PED Potassium EDTA<br />
BBL CultureSwab Kit PRO ProbeTec Media<br />
DFA Desferoxamine RLS Ringer's Lactate Solution<br />
EDT EDTA RNL RNALater<br />
END Endometrial Tissue ROC Roche Media<br />
ETH Ethanol RPM RPMI 1640 Medium<br />
FFN Fetal Fibronectin Buffer<br />
PI1 S8820 Sigma SIGMAFAST? Protease<br />
FMD Formaldehyde SST<br />
Inhibitor Tablets<br />
Serum Separator<br />
FOR Formalin SKM Skim Milk<br />
GEN GenAptima Media<br />
STG Skim milk-Tryptone-Glucose-Glycerin<br />
Medium (STGG)<br />
GLT Glutaraldehyde SNP Snap/Flash Frozen<br />
GIT Guanidine Isothiocyanate (GITC) SCI Sodium Citrate<br />
GRB Guanidine Reduction Buffer SED Sodium EDTA<br />
HEP Heparin SFL Sodium Fluoride<br />
IST Internal Standard SPH Sucrose Phosphate<br />
ISO Isohelix kit SPO Sodium Fluoride/Potassium Oxalate<br />
LPE Liquid Potassium EDTA SPS Sodium Polyanetholesulfonate<br />
LSE Liquid Sodium EDTA DPE Spray Dried Potassium EDTA<br />
LHP Lithium Heparin DSE Spray Dried Sodium EDTA<br />
LHG Lithium Heparin and Gel for Plasma SCC Steck Cyto-Chex tubes - stabilized<br />
MPA Metaphosphoric Acid SPH Sucrose Phosphate<br />
NON None TEM Tempus Tube<br />
NSL Normal Saline THM Thrombin<br />
NOR Normasol TFM Tissue Freezing Medium<br />
OCT Optimum Cutting Temperature Medium TMS Transport Medium-Stuarts<br />
ORG Oragene Collection Container UNK Unknown Additive<br />
ORA OraSure Collection Container VTM Viral Transport Media<br />
OTH Other H2O Water<br />
Frontier Science Foundation 384 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>LDMS</strong> Derivative <strong>Codes</strong><br />
Refer to the <strong>LDMS</strong> Reports module for a complete listing of <strong>LDMS</strong> <strong>Codes</strong>.<br />
ADL Adipose Tissue Layer NKC Natural Killer Cells<br />
AMN Amniotic Fluid NCL Neutrophil (PMN) - Viable cells<br />
APL Applicator Tip<br />
NPE Neutrophil (PMN) Dried Cell Pellet, Non<br />
Viable<br />
ASP Aspirate NON None<br />
BPS Biopsy NXD Non-extracted DNA<br />
BLD Blood (Whole)<br />
PEN Non-viable cells from non-blood<br />
specimen type<br />
BMA Bone Marrow Aspirate PEL Non-viable PBMC s<br />
BMC Bone Marrow Core Biopsy<br />
N/A Not Applicable - Same as Primary<br />
Specimen Type<br />
BRN Brain Tissue OTH Other<br />
BMK Breast Milk OPC Ova & Parasite Concentrate<br />
BML Breast Milk - Left CEL PBMC Cells, Viable<br />
BMR Breast Milk - Right FSI Penis Foreskin, Inner Tissue<br />
BMS Breast Milk - Spun FSO Penis Foreskin, Outer Tissue<br />
BMW Breast Milk - Whole UMB Placenta - Cord Slice<br />
BRS Breast Tissue PLM Placenta - Membrane Slice<br />
BAL Bronchoalveolar Lavage PLT Placenta - Placenta Slice<br />
BUC Buccal Cells PLC Placental Tissue<br />
CAN Candida PLH Plasma High Spin<br />
CD4 CD4 Positive T-Cells PL* Plasma, All<br />
CLI Cell Lines PL2 Plasma, Double-Spun<br />
CTC Cells from a CTL Assay DPL Plasma, Dried<br />
CGN Cells in GITC DPE Plasma, Dried Extract<br />
CIO Cells in Other (Solution), Non-<br />
Viable<br />
FPL Plasma, Filtered<br />
CSF Cerebro-Spinal Fluid<br />
CXS Cervical Swab PL1 Plasma, Single-Spun<br />
CVL Cervical Vaginal Lavage PLA Plasma, Unknown Processing<br />
CCC Cryopreserved Cells from a Culture,<br />
Viable<br />
PDC Plasmacytoid Dendritic Cells<br />
CLN Cryopreserved primary cells from STK Quantitative Culture Held beyond 14<br />
Non-Blood Spec Type, Viable<br />
Days<br />
SUP Culture Supernatant REC Rectal<br />
PCC Culture Supernatant and Cells RBC Red Blood Cells<br />
CTB Cytobrush SAL Saliva<br />
CMV CytoMegaloVirus Isolate SEC Secretions<br />
DSP Digested Sputum SEM Semen<br />
DBE Dried Blood Extract SER Serum<br />
DBS Dried Blood Spot CSR Serum - Chilled<br />
PED Dried Pellet - Digene SRH Serum - High Speed Spun<br />
PER Dried Pellet - Roche SKN Skin<br />
DPS Dried Plasma Spot SLD Slide from a primary sample<br />
DWB Dried Whole Blood SMR Smear<br />
CDP Dry Pellet from a Culture, Non<br />
Viable<br />
SNO SNO - Strip<br />
END Endometrial Tissue SPG Sponge<br />
XDA Extracted DNA DPE Spray Dried EDTA<br />
XFL Extracted Fluid from RNA RT PCR WFS Stimulated whole blood cells, lysed,<br />
for Sequencing<br />
fixed, frozen (with DMSO) for flow<br />
XPD Extracted Pellet from DNA PCR for<br />
Sequencing<br />
STL Stool<br />
Frontier Science Foundation 385 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
XPR Extracted Pellet from RNA RT PCR PLP Supernatant & Cells from a Quantitative<br />
for Sequencing<br />
Culture<br />
XPA Extracted RNA SDI Supernatant Dermis, Inner<br />
FLD Fluid Portion from a Non-Blood<br />
Specimen Type<br />
SDO Supernatant Dermis, Outer<br />
CEN Fresh Cells from a Non-Blood<br />
Spec. Type<br />
SEI Supernatant Epidermis, Inner<br />
CRY Generic Cryptococcus SEO Supernatant Epidermis, Outer<br />
HAR Hair SPQ Supernatant from a Quantitative Culture<br />
BHR Hair, Body<br />
CTS Supernatant generated from a CTL<br />
Assay<br />
FHR Hair, Facial<br />
ICK Supernatant generated from Inducible<br />
Cytokines<br />
PHR Hair, Pubic SWB Swab<br />
SHR Hair, Scalp TFS Tear-Flo Strips<br />
IVR Intra vaginal Ring THW Throat Wash<br />
LAV Lavage THY Thymus<br />
LPK Leukopak TIS Tissue<br />
LPD Lipid Layer BLK Tissue Block<br />
LIV Liver Tissue TON Tonsillar Biopsy/Aspirate<br />
LYM Lymph Node Biopsy/Aspirate TRU Trucount<br />
LYS Lysed whole blood<br />
BUF Unficolled Cryopreserved Buffy Coat,<br />
Viable<br />
MCL Macrophage Cells - Viable SPT Unfractioned Sputum<br />
MPE Macrophage Dried Cell Pellet, Non<br />
Viable<br />
SPI Unfractioned Sputum, Induced<br />
MEC Meconium UNK Unknown Derivative<br />
IPK Methanol Extract Supernatant<br />
WFC Unstimulated whole blood cell, lysed ,<br />
fixed, frozen (with DMSO) for flow<br />
MCS Microbiology Culture Slant URN Urine<br />
MTB MTB Isolates VAG Vaginal<br />
MUC Mucins PEO Wet Pellet Prep - Organon Teknika<br />
MDC Myeloid Dendritic Cells W/D Wet/Dry<br />
NPW Nasopharyngeal Wash WPK Whole Blood Packed<br />
WBP Whole Blood Pellet, Specify<br />
Methodology<br />
WEK Wick/Wek Cell Sponge<br />
Frontier Science Foundation 386 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>LDMS</strong> Sub Additive/Derivative <strong>Codes</strong><br />
Refer to the <strong>LDMS</strong> Reports module for a complete listing of <strong>LDMS</strong> <strong>Codes</strong>.<br />
TCA 1% Thimersol/ 6.6% EACA (Epsilon<br />
Amino Caproic Acid)<br />
DCF 2 - deoxycoformycin.<br />
GLY 20% Glycerol<br />
ADA Adenosine Deaminase<br />
MUC Mucins<br />
TSC Myeloid dendritic cell infect w/ Sendai<br />
Cantell & treat w/ TSST<br />
TND Myeloid dendritic cell infected with NDVW<br />
and treated with TSST<br />
TMD Myeloid dendritic cell non infected and<br />
ATC Animal Tumor Cell Line NCL<br />
treated with TSST<br />
N-acetyl-L-cysteine<br />
APR Aprotinin NDV NDVB1, Newcastle disease virus wild type<br />
ASC Ascorbate (Vit C)<br />
NDN NDVNS1, Newcastle disease virus with<br />
NS1 influenza protein<br />
AUO Auramine O NPI Neuropepsidase Inhibitor<br />
BCG Bacille Calmette-Gu‚rin<br />
NDW Newcastle disease virus with W influenza<br />
BCL B-cell Lymphoblastoid Cell Line NON<br />
protein<br />
None<br />
BML Breast - Left NSL Normal Saline<br />
BMR Breast - Right N/A Not Applicable<br />
CAN Candida (CASTA) NUC Nucleotides<br />
CCM CareHPV Collection Medium OKT OKT3 Treated<br />
CON Control OCT Optimum Cutting Temperature Medium<br />
SUP Cultural Supernatant P24 P24<br />
CME Culture Media PFM Paraformaldahyde<br />
CYT Cytokines PAR Parrafin<br />
CMV CytoMegaloVirus PHA PHA-Treated<br />
CSP Cytospin Slides PMI Phorbol Myristate Acetate-Ionomycin<br />
DEA DEACTIVATED PBS Phosphate Buffered Saline<br />
DPL Depleted Cell Populations PPA Phosphoric Acid<br />
DTM Digene/Qiagen Specimen Transport<br />
PLD Plasma, Depleted<br />
Medium<br />
DMS Dimethylsulfoxide (DMSO) PWM Pokeweed Mitogen<br />
DTT Dithiothreitol PVA Polyvinyl alcohol<br />
EDT EDTA PCS PreserveCytSolution<br />
ETH Ethanol RTB Reverse Transcriptase buffer<br />
FBS Fetal Bovine Serum RGT Right<br />
FOR Formalin RNP RNA Protect<br />
FUN Fungal Broth RNL RNAlater<br />
GMS Giemsa Staining RFW RNAse free water<br />
GLT Glutaraldehyde RPM RPMI 1640 Medium<br />
GLM Glycerol Media<br />
PI1 S8820 Sigma SIGMAFAST Protease<br />
Inhibitor Tablets<br />
GRS Gram Stain<br />
S52 Sendai 52 virus with defective infectious<br />
particules<br />
GIT Guanidine Isothiocyanate (GITC) SEB Sigma Staphylococcus Enterotoxin B<br />
HPA Hep A<br />
STG Skim milk-Tryptone-Glucose-Glycerin<br />
H&E Hematoxylin and Eosin Stain SCB<br />
Medium (STGG)<br />
Sodium Carbonate<br />
GAG HIV GAG envelope peptide NOH Sodium Hydroxide<br />
HTC Human Tumor Cell Line STM Stimulated by Multiple Antigens<br />
HCl Hydrochloric Acid TCL T-cell Lymphoblastoid Cell Line<br />
ILA IL-12/IL-15, Interleukin-12/Interleukin-15 TEM Tempus Tube<br />
I18 IL-18 TTX Tetanus Toxoid treated<br />
Frontier Science Foundation 387 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
I1b IL-1b TFM Tissue Freezing Medium<br />
IL2 IL-2, Interleukin 2 TOC Tocopherol (Vit E)<br />
INK India Ink TMS Transport Medium-Stuarts<br />
IAP Iodoacetic Acid/Phenanthrolene TRI TriReagent<br />
562 K562 Cell Line TCM Trichrome Stain<br />
LFT Left TRX Triton X<br />
LES Lesion TRZ Trizol<br />
LPS Lipopolysaccaride TNV TSST with NDVB1<br />
LVT L-var Target TNN TSST with NDVNS1<br />
LYB Lysis Buffer TSS TSST, Toxic-Shock Syndrome Toxin<br />
MAS M. Avium Sensitin UNK Unknown Sub A/D<br />
MA1 MAC 101 UNT Untreated / Unstimulated<br />
MAC MAC Antigen VTM Viral Transport Media<br />
MAF MAC LR114F Culture Filtrate VIR Virus<br />
MIF Merthoilate Formalin/Merthiolate-Iodine<br />
Formalin (MF/MIF)<br />
VPS VP Stimulator<br />
MRN Messenger RNA VPT VP Target<br />
MET Methanol H2O Water<br />
MT2 MT2 Cell Line DPH Wyeth Ayerst Diphtheria Antigen<br />
ZLN Ziehl Neelsen<br />
Frontier Science Foundation 388 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
<strong>LDMS</strong> Miscellaneous <strong>Codes</strong><br />
Refer to the <strong>LDMS</strong> Reports module for a complete listing of <strong>LDMS</strong> <strong>Codes</strong>.<br />
Measurement<br />
CEL Cells MM Millimeters<br />
CM Centimeters N/A Not Applicable<br />
EA Each PG Picograms<br />
Fmole Femtomole Pmole Picomole<br />
GR Grams UG Micrograms<br />
MG Milligrams UL Microliters<br />
ML Milliliters UNK Unknown Units<br />
VID Units<br />
A A POR Post study & redraw<br />
B B CFM Post Study Confirmation Test<br />
B/L Baseline SRV Post Study Service Test<br />
Bth Birth Pst Post-Infusion<br />
Ch Challenge Pos Post-Study<br />
Cb Cord Blood PE Pre-entry<br />
Day Days Pri Pre-Infusion<br />
EOX End of Study & possible recent<br />
Prf Proficiency<br />
exposure<br />
EOR End of Study & redraw Qul Qualification<br />
Eos End-Of-Study Exp Recent Exposure<br />
Ent Entry/Baseline Rdw Redraw<br />
Ext Exit/Discontinuation Scr Screening<br />
FUP Follow-up Test SP Sero Positive<br />
Inf Infected Participant Testing SC Seroconversion<br />
L&D Labor & Delivery SCK Sick<br />
Mo Months Sps Special Studies<br />
OFP Off PrEP UnK Unknown<br />
ONP On PrEP Uns Unscheduled<br />
Gel On study without gel Vst Visit<br />
PPt Post Partum Wk Weeks<br />
POX Post study & possible recent<br />
exposure<br />
Yr Years<br />
Time Units<br />
Day Day Pst Post-Fasting<br />
Fst Fasting Prd Predialyzer<br />
Hrs Hours Pre Pre-Dose<br />
Min Minutes Ran Random<br />
Nft Non-Fasting RPD Random Post Dose<br />
Pol Pooled Sec Seconds<br />
Psd Postdialyzer Tr Trough<br />
UNK Unknown Time Unit<br />
Conditions<br />
CLT Clotted LBE Lab Error<br />
Frontier Science Foundation 389 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
COC Combination of Conditions (Explain) LIP Lipemic<br />
CTM Contaminated LSH Lost Shipment<br />
DSH Delayed Shipment LYS Lysed<br />
DSR Destroyed OTH Other (Explain)<br />
DIM Dry Ice Melted PST Processed after Specified Time<br />
EQF Equipment Failure QNS Quantity Not Sufficient<br />
EXP Expired REF Refrigerated<br />
HUM Exposed to high humidity SNC Sample not collected<br />
FRO Frozen SNR Sample Not Received,CRF Received<br />
HEM Hemolyzed SAT Satisfactory<br />
ICT Icteric (Excess Bilirubin)<br />
TNO Shipping/storage temperature not<br />
optimal/warmed<br />
INT Incorrect Tube TWD Thawed<br />
INV Invalid Specimen UNK Unknown Condition<br />
<strong>LDMS</strong> Assay Censor <strong>Codes</strong><br />
Specimen Management<br />
Reasons for Not Running an Assay<br />
CTM Contaminated NPA<br />
Sample drawn without patient<br />
adherence to regimen<br />
COR Controls out of range OUT Resulted outside the <strong>LDMS</strong><br />
EQF Equipment failure PSW<br />
Sample not drawn within protocolspecified<br />
window<br />
LBA Laboratory accident QNS Quantity not sufficient<br />
LBE Lab error WCT Wrong controls<br />
MSW Missing well STO Specimen too old to run on test<br />
Immunology<br />
User Censors<br />
C Contamination R Not required<br />
E Tech error/Lab error S Quantity not sufficient<br />
K Kit/Reagent problem V Poor viability<br />
N Not done<br />
Reasons Why Results Were Not Obtained<br />
A Wrong anticoagulant P Results reported under a different protocol<br />
C Contamination S Quantity not sufficient<br />
E Tech error/Lab error U Unsatisfactory sample<br />
K Kit/Reagent problem V Poor viability<br />
Pharmacology<br />
System Censors<br />
B Below quant. limit<br />
L Lower limit adjusted up for this run<br />
R Repeat (with L system censor only)<br />
User Censors<br />
A<br />
Invalid. Greater than the upper limit,<br />
dilute and repeat<br />
Q Not Quantifiable<br />
B Below quant. limit or no peak S Quantity Not Sufficient<br />
D Drug not required to be assayed X Per lab, sample must be repeated<br />
O QC out of range, dilute and repeat Z No result, lab issue<br />
Frontier Science Foundation 390 October 2011
<strong>LDMS</strong> User Manual<br />
User Censors<br />
<strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
P Not able to interpret result<br />
Virology<br />
User Censors<br />
B1 BOOM extraction used P Equipment failure<br />
C<br />
Control re-run and valid <strong>–</strong> assay is<br />
valid<br />
Q Kit QC out of range <strong>–</strong> repeat<br />
D Contamination V Over-amplified<br />
E Poor viability W Inhibitory/Material did not amplify<br />
K Kit/Reagent problem Z Per lab, do not use<br />
O Lab error/Lab accident R Re-detected<br />
Abbott Realtime HIV-1 Assay (System Censors)<br />
F Invalid Control J Undetectable<br />
G<br />
Results less than lower limit of<br />
quantification<br />
H No Result<br />
X4<br />
Results greater than upper limit of<br />
quantification<br />
Roche Amplicor HIV Monitor (RT PCR) Assay (System Censors)<br />
A QS wells below lower limit L(HIV) HIV wells out of sequence<br />
B QS wells above upper limit L(QS) QS wells out of sequence<br />
C User re-selected well for algorithm R Re-read<br />
D OD ratio failure <strong>–</strong> repeat U<br />
Undetectable sample above cutoff <strong>–</strong><br />
repeat<br />
F Control out of range X2 Invalid standards <strong>–</strong> slope negative.<br />
I No QS wells in range X3 Invalid/Out of sequence control<br />
J<br />
HIV wells below lower limit <strong>–</strong> no HIV<br />
RNA detected<br />
X4<br />
Copies greater than the upper limit of<br />
quantification <strong>–</strong> dilute and repeat<br />
K HIV wells above upper limit<br />
Roche Amplicor HIV-1 Monitor UltraSensitive Assay (System Censors)<br />
A QS wells below lower limit L(HIV) HIV wells out of sequence<br />
B QS wells above upper limit L(QS) QS wells out of sequence<br />
C User re-selected well for algorithm R Re-read<br />
D OD ratio failure <strong>–</strong> repeat U<br />
Undetectable sample above cutoff <strong>–</strong><br />
repeat<br />
F Control out of range X2 Invalid standards <strong>–</strong> slope negative.<br />
I No QS wells in range X3 Invalid/Out of sequence control<br />
J<br />
HIV wells below lower limit <strong>–</strong> no HIV<br />
RNA detected<br />
X4<br />
Copies greater than the upper limit of<br />
quantification <strong>–</strong> dilute and repeat<br />
K HIV wells above upper limit<br />
Roche COBAS Amplicor HIV-1 Monitor Test (System Censors)<br />
F Invalid control J Undetectable<br />
I No QS wells in range K Wells out of range<br />
G<br />
Copies less than lower limit of<br />
quantification<br />
L(HIV) HIV wells out of sequence<br />
X4<br />
Copies greater than upper limit of<br />
quantification<br />
L(QS) QS wells out of sequence<br />
X3 Invalid/Out of sequence control R Re-read<br />
Frontier Science Foundation 391 October 2011
<strong>LDMS</strong> User Manual <strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
Roche COBAS Amplicor HIV-1 Monitor Test, UltraSensitive (System Censors)<br />
F Invalid control J Undetectable<br />
I No QS wells in range K Wells out of range<br />
G<br />
Copies less than lower limit of<br />
quantification<br />
L(HIV) HIV wells out of sequence<br />
X4<br />
Copies greater than upper limit of<br />
quantification<br />
L(QS) QS wells out of sequence<br />
X3 Invalid/Out of sequence control R Re-read<br />
HIV DNA PCR (Roche Amplicor Detect) (System Censors)<br />
A 0 control not negative M<br />
Converted from RLMP <strong>–</strong> Out of range<br />
controls<br />
B 10 control not positive N Converted from RLMP <strong>–</strong> Lipemia<br />
C 20 control not positive U<br />
Converted from RLMP <strong>–</strong> Unable to<br />
calculate<br />
D 20 control OD ≤ 2.000 H Converted from RLMP <strong>–</strong> Clotted<br />
E Blind pellet invalid T<br />
Converted from RLMP <strong>–</strong> Prerequisite test<br />
failed<br />
F Previous runs invalid <strong>–</strong> Assay locked O Converted from RLMP <strong>–</strong> Lab error<br />
R Re-read Q Converted from RLMP <strong>–</strong> QNS<br />
P<br />
Converted from RLMP <strong>–</strong> Equipment<br />
failure<br />
W<br />
Converted from RLMP <strong>–</strong> Material didn’t<br />
amplify<br />
G<br />
Converted from RLMP <strong>–</strong><br />
Contamination<br />
Y<br />
Converted from RLMP <strong>–</strong> No description<br />
available<br />
L<br />
Converted from RLMP <strong>–</strong> Missing<br />
well<br />
NASBA HIV-1 RNA Assay (System Censors)<br />
A Invalid standards <strong>–</strong> slope negative D Converted from RLMP <strong>–</strong> Contamination<br />
B Controls out of sequence T<br />
Converted from RLMP <strong>–</strong> Prerequisite test<br />
failed<br />
I Invalid specimen E Converted from RLMP <strong>–</strong> Poor viability<br />
J WT < LDL, Undetectable Q<br />
Converted from RLMP <strong>–</strong><br />
Improper/Questionable ID<br />
R Re-read U<br />
Converted from RLMP <strong>–</strong> Unable to<br />
calculate<br />
M<br />
Converted from RLMP <strong>–</strong> Out of<br />
range controls<br />
V Converted from RLMP <strong>–</strong> Over-amplified<br />
H Converted from RLMP <strong>–</strong> Broken tube W<br />
Converted from RLMP <strong>–</strong> Material didn’t<br />
amplify<br />
G Converted from RLMP <strong>–</strong> QNS O Converted from RLMP <strong>–</strong> Lab error<br />
F<br />
Converted from RLMP <strong>–</strong> Incorrect<br />
tube<br />
K<br />
Converted from RLMP <strong>–</strong> No sample<br />
received<br />
L<br />
Converted from RLMP <strong>–</strong> Laboratory<br />
accident<br />
X Converted from RLMP <strong>–</strong> Delayed shipment<br />
P<br />
Converted from RLMP <strong>–</strong> Equipment<br />
failure<br />
Y Converted from RLMP <strong>–</strong> Missing well<br />
Nuclisens HIV-1 QT Assay (System Censors)<br />
A Invalid slope D Converted from RLMP <strong>–</strong> Contamination<br />
B Controls out of sequence T<br />
Converted from RLMP <strong>–</strong> Prerequisite test<br />
failed<br />
I Invalid specimen E Converted from RLMP <strong>–</strong> Poor viability<br />
J WT < LDL, Undetectable Q<br />
Converted from RLMP <strong>–</strong><br />
Improper/Questionable ID<br />
R Re-read U<br />
Converted from RLMP <strong>–</strong> Unable to<br />
calculate<br />
Frontier Science Foundation 392 October 2011
<strong>LDMS</strong> User Manual<br />
Nuclisens HIV-1 QT Assay (System Censors)<br />
<strong>Appendix</strong> A <strong>–</strong> <strong>LDMS</strong> <strong>Codes</strong><br />
M<br />
Converted from RLMP <strong>–</strong> Out of range<br />
controls<br />
V Converted from RLMP <strong>–</strong> Over-amplified<br />
H Converted from RLMP <strong>–</strong> Broken tube W<br />
Converted from RLMP <strong>–</strong> Material didn’t<br />
amplify<br />
G Converted from RLMP <strong>–</strong> QNS O Converted from RLMP <strong>–</strong> Lab error<br />
F<br />
Converted from RLMP <strong>–</strong> Incorrect<br />
tube<br />
K<br />
Converted from RLMP <strong>–</strong> No sample<br />
received<br />
L<br />
Converted from RLMP <strong>–</strong> Laboratory<br />
accident<br />
X Converted from RLMP <strong>–</strong> Delayed shipment<br />
P<br />
Converted from RLMP <strong>–</strong> Equipment<br />
failure<br />
Y Converted from RLMP <strong>–</strong> Missing well<br />
P24 (System Censors)<br />
A Invalid standards <strong>–</strong> slope negative D Kit controls out of sequence<br />
B VQA standards out of sequence R Re-read<br />
C Missing media controls<br />
Frontier Science Foundation 393 October 2011